Delcath Systems Company Profile (NASDAQ:DCTH)

About Delcath Systems (NASDAQ:DCTH)

Delcath Systems logoDelcath Systems, Inc. is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The Company's system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Prosthetics
  • Sub-Industry: N/A
  • Symbol: NASDAQ:DCTH
  • CUSIP: N/A
  • Web: www.delcath.com
Capitalization:
  • Market Cap: $74.48 million
  • Outstanding Shares: 118,457,000
Average Prices:
  • 50 Day Moving Avg: $0.13
  • 200 Day Moving Avg: $0.17
  • 52 Week Range: $0.02 - $6.49
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: $2.37 million
  • Price / Sales: 7.19
  • Book Value: ($0.01) per share
  • Price / Book: -28.76
Profitability:
  • EBIDTA: ($16,900,000.00)
  • Net Margins: -1,161.00%
  • Return on Equity: -1,403.27%
  • Return on Assets: -76.07%
Debt:
  • Current Ratio: 0.97%
  • Quick Ratio: 0.94%
Misc:
  • Average Volume: 88.46 million shs.
  • Beta: 0.1
  • Short Ratio: 0.14
 

Frequently Asked Questions for Delcath Systems (NASDAQ:DCTH)

What is Delcath Systems' stock symbol?

Delcath Systems trades on the NASDAQ under the ticker symbol "DCTH."

How were Delcath Systems' earnings last quarter?

Delcath Systems, Inc. (NASDAQ:DCTH) issued its quarterly earnings results on Friday, November, 11th. The company reported ($0.66) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($3.29) by $2.63. The company had revenue of $0.44 million for the quarter. Delcath Systems had a negative net margin of 1,161.00% and a negative return on equity of 1,403.27%. During the same quarter last year, the company posted ($1.96) EPS. View Delcath Systems' Earnings History.

Are investors shorting Delcath Systems?

Delcath Systems saw a increase in short interest in the month of June. As of June 15th, there was short interest totalling 21,463,653 shares, an increase of 24.8% from the May 31st total of 17,195,398 shares. Based on an average daily trading volume, of 131,428,063 shares, the days-to-cover ratio is currently 0.2 days. Approximately 12.8% of the shares of the company are short sold.

Who are some of Delcath Systems' key competitors?

Who are Delcath Systems' key executives?

Delcath Systems' management team includes the folowing people:

  • Roger G. Stoll Ph.D., Chairman of the Board
  • Jennifer K. Simpson Ph.D., President, Chief Executive Officer, Director
  • Barbra C. Keck, Principal Financial Officer, Senior Vice President - Finance, Principal Accounting Officer, Secretary
  • John Purpura, Executive Vice President - Regulatory Affairs and Quality Assurance
  • Harold S. Koplewicz M.D., Independent Director
  • William Dodge Rueckert, Independent Director
  • Marco Taglietti M.D., Independent Director

Who owns Delcath Systems stock?

Delcath Systems' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include AYRTON CAPITAL LLC (8.40%). Company insiders that own Delcath Systems stock include Laura A Philips and William Dodge Rueckert. View Institutional Ownership Trends for Delcath Systems.

How do I buy Delcath Systems stock?

Shares of Delcath Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Delcath Systems' stock price today?

One share of Delcath Systems stock can currently be purchased for approximately $0.14.


MarketBeat Community Rating for Delcath Systems (NASDAQ DCTH)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  78
MarketBeat's community ratings are surveys of what our community members think about Delcath Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Delcath Systems (NASDAQ:DCTH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Delcath Systems (NASDAQ:DCTH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/4/2016WallachBeth CapitalInitiated CoverageBuy$1.00N/AView Rating Details
(Data available from 7/22/2015 forward)

Earnings

Earnings History for Delcath Systems (NASDAQ:DCTH)
Earnings by Quarter for Delcath Systems (NASDAQ:DCTH)
Earnings History by Quarter for Delcath Systems (NASDAQ DCTH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/11/2016Q3 2016($3.29)($0.66)$0.44 millionViewN/AView Earnings Details
8/16/2016Q2($4.41)$466.00 million$511.00 millionViewN/AView Earnings Details
5/4/2016Q1($0.19)($0.08)$0.37 millionViewN/AView Earnings Details
3/21/2016Q415($0.23)$0.44 millionViewN/AView Earnings Details
11/10/2015Q3($0.12)$0.40 millionViewN/AView Earnings Details
8/5/2015Q2($0.30)$251.00 million$466.00 millionViewN/AView Earnings Details
3/10/2015Q414($0.31)$0.29 millionViewN/AView Earnings Details
5/7/2014Q114($0.64)($0.57)$0.20 million$0.31 millionViewListenView Earnings Details
3/12/2014Q413($0.05)($0.04)$0.10 million$0.30 millionViewListenView Earnings Details
11/6/2013Q313($0.08)($0.07)$0.30 million$0.07 millionViewListenView Earnings Details
8/6/2013Q2 2013($0.11)($0.06)$0.30 millionViewListenView Earnings Details
5/8/2013Q1 2013($0.13)($0.15)$0.28 million$0.30 millionViewListenView Earnings Details
8/7/2012($0.30)($0.26)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Delcath Systems (NASDAQ:DCTH)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Delcath Systems (NASDAQ:DCTH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Delcath Systems (NASDAQ:DCTH)
Insider Ownership Percentage: 4.50%
Institutional Ownership Percentage: 0.57%
Insider Trades by Quarter for Delcath Systems (NASDAQ:DCTH)
Institutional Ownership by Quarter for Delcath Systems (NASDAQ:DCTH)
Insider Trades by Quarter for Delcath Systems (NASDAQ:DCTH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/23/2015Laura A PhilipsDirectorBuy162,653$0.50$81,326.50View SEC Filing  
7/22/2015William Dodge RueckertDirectorBuy20,000$0.48$9,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Delcath Systems (NASDAQ:DCTH)
Latest Headlines for Delcath Systems (NASDAQ:DCTH)
Source:
DateHeadline
americanbankingnews.com logoReviewing Delcath Systems (DCTH) & Wright Medical Group N.V. (WMGI)
www.americanbankingnews.com - July 19 at 8:51 AM
seekingalpha.com logoDelcath Systems' Second Attempt At Shareholder Approval For Reverse Split - Seeking Alpha
seekingalpha.com - July 14 at 8:46 PM
seekingalpha.com logoDelcath Systems Share Price Has Risen Over 1000% In The Past Month On No News And Is Engaged In Death Spiral ... - Seeking Alpha
seekingalpha.com - July 12 at 6:30 PM
seekingalpha.com logoDelcath Systems May Take Off In The Near Future - Seeking Alpha
seekingalpha.com - July 11 at 7:00 PM
seekingalpha.com logoDelcath Systems Offers Significant Upside For Risk-Tolerant Investors - Seeking Alpha
seekingalpha.com - July 10 at 5:46 PM
americanbankingnews.com logoDelcath Systems (DCTH) vs. Insulet Corporation (PODD) Financial Contrast
www.americanbankingnews.com - July 10 at 8:23 AM
americanbankingnews.com logoComparing Wright Medical Group N.V. (WMGI) & Delcath Systems (NASDAQ:DCTH)
www.americanbankingnews.com - July 2 at 7:54 AM
americanbankingnews.com logoReWalk Robotics (RWLK) versus Delcath Systems (DCTH) Critical Review
www.americanbankingnews.com - June 28 at 8:36 AM
americanbankingnews.com logoShort Interest in Delcath Systems, Inc. (DCTH) Grows By 24.8%
www.americanbankingnews.com - June 28 at 7:04 AM
americanbankingnews.com logoContrasting Delcath Systems (DCTH) & ReWalk Robotics (RWLK)
www.americanbankingnews.com - June 26 at 4:14 PM
seekingalpha.com logoDelcath continues up move; shares ahead 75% - Seeking Alpha
seekingalpha.com - June 21 at 6:03 PM
americanbankingnews.com logoShort Interest in Delcath Systems, Inc. (DCTH) Rises By 47.4%
www.americanbankingnews.com - June 11 at 7:16 AM
americanbankingnews.com logoHead-To-Head Survey: Alkermes Plc (ALKS) vs. Delcath Systems (DCTH)
www.americanbankingnews.com - June 8 at 12:50 PM
globenewswire.com logoDelcath Systems, Inc. Announces Adjournment of Annual Meeting ... - GlobeNewswire (press release)
globenewswire.com - June 6 at 9:58 PM
nasdaq.com logoDelcath Systems, Inc. Announces Adjournment of Annual Meeting ... - Nasdaq
www.nasdaq.com - June 6 at 4:57 PM
finance.yahoo.com logoDelcath Systems, Inc. Announces Adjournment of Annual Meeting Meeting Scheduled to Reconvene on June 16
finance.yahoo.com - June 5 at 9:45 PM
americanbankingnews.com logoDelcath Systems, Inc. (DCTH) Short Interest Up 23.7% in April
www.americanbankingnews.com - May 11 at 8:38 AM
rttnews.com logoEARNINGS SUMMARY: Details of Delcath Systems Inc. Q1 Earnings Report
www.rttnews.com - May 10 at 9:52 PM
finance.yahoo.com logoDelcath Announces First Quarter 2017 Financial Results
finance.yahoo.com - May 9 at 4:38 PM
americanbankingnews.com logoDelcath Systems (DCTH) Receiving Somewhat Favorable News Coverage, Analysis Finds
www.americanbankingnews.com - May 3 at 1:05 AM
americanbankingnews.com logoDelcath Systems (DCTH) Earns News Impact Score of 0.07
www.americanbankingnews.com - April 29 at 9:35 PM
finance.yahoo.com logoDelcath Issues Letter to Stockholders
finance.yahoo.com - April 27 at 8:20 AM
americanbankingnews.com logoDelcath Systems, Inc. (DCTH) Short Interest Update
www.americanbankingnews.com - April 27 at 7:02 AM
americanbankingnews.com logoDelcath Systems (DCTH) Receives Daily Media Impact Score of -0.10
www.americanbankingnews.com - April 26 at 1:46 PM
americanbankingnews.com logoDelcath Systems (DCTH) Getting Somewhat Favorable Media Coverage, Study Finds
www.americanbankingnews.com - April 20 at 4:56 PM
finance.yahoo.com logoSpire Southampton Hospital in UK Celebrating Over 100 CHEMOSAT Treatments
finance.yahoo.com - April 18 at 12:06 PM
americanbankingnews.com logoDelcath Systems (DCTH) Earning Somewhat Favorable News Coverage, Study Shows
www.americanbankingnews.com - April 16 at 10:17 AM
americanbankingnews.com logoSomewhat Positive News Coverage Very Unlikely to Impact Delcath Systems (DCTH) Stock Price
www.americanbankingnews.com - April 13 at 3:50 PM
biz.yahoo.com logoDELCATH SYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi
biz.yahoo.com - April 3 at 5:05 PM
finance.yahoo.com logoDELCATH SYSTEMS, INC. Financials
finance.yahoo.com - April 1 at 4:52 PM
biz.yahoo.com logoDELCATH SYSTEMS, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 29 at 11:51 AM
finance.yahoo.com logoDelcath Announces 2016 Financial Results
finance.yahoo.com - March 29 at 11:51 AM
streetinsider.com logoDelcath Systems (DCTH) Announces SPA Agreement with FDA for Pivotal Trial With Melphalan/HDS in Intrahepatic Cholangiocarcinoma
www.streetinsider.com - March 28 at 12:15 PM
streetinsider.com logoDelcath Systems (DCTH) Announces SPA Agreement with FDA for ... - StreetInsider.com
www.streetinsider.com - March 27 at 4:32 PM
investopedia.com logoDelcath Clinical Study Design Approved By FDA
www.investopedia.com - March 27 at 4:32 PM
rttnews.com logoDelcath Reaches SPA Deal With FDA On Pivotal Trial Of Melphalan Hydrochloride
www.rttnews.com - March 27 at 12:16 PM
us.rd.yahoo.com logoDelcath Announces Special Protocol Assessment Agreement With FDA for Pivotal Trial With Melphalan/HDS in Intrahepatic Cholangiocarcinoma
us.rd.yahoo.com - March 27 at 12:16 PM
americanbankingnews.com logoDelcath Systems, Inc. (DCTH) to Release Earnings on Monday
www.americanbankingnews.com - March 17 at 9:06 PM
globenewswire.com logoDelcath Systems To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 13, 2017 - GlobeNewswire (press release)
globenewswire.com - March 11 at 4:33 PM
nasdaq.com logoDelcath Systems To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 13
www.nasdaq.com - March 10 at 5:46 PM
streetinsider.com logoDelcath Systems (DCTH) Says Published Review Shows Its Investigational PHP Doubles Overall Survival Over Other Targeted Liver Therapies
www.streetinsider.com - February 22 at 10:00 PM
us.rd.yahoo.com logoPublished Review Shows Delcath Investigational PHP Doubles Overall Survival Over Other Targeted Liver Therapies
us.rd.yahoo.com - February 22 at 10:00 PM
us.rd.yahoo.com logo8:02 am Delcath announces publication of a review of investigational PHP with Melphalan/HDS in the American Journal of Clinical Oncology
us.rd.yahoo.com - February 22 at 10:00 PM
biz.yahoo.com logoDELCATH SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - February 22 at 4:58 PM
finance.yahoo.com logoAnalysis From Two Institutions Shows Strong Tumor Response, Overall Survival Potential of Delcath Investigational PHP Therapy
finance.yahoo.com - February 22 at 5:32 AM
finance.yahoo.com logo8:14 am Delcath announces a study demonstrated that 45.7% of patients with ocular melanoma that metastasized to the liver who underwent percutaneous hepatic perfusion using investigational Melphalan/HDS experienced a complete or partial res
finance.yahoo.com - February 22 at 5:32 AM
biz.yahoo.com logoDELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
biz.yahoo.com - February 16 at 2:15 PM
finance.yahoo.com logoDelcath Systems to Present at the 2nd Annual Disruptive Growth & Healthcare Conference
finance.yahoo.com - February 6 at 4:46 PM
biz.yahoo.com logoDELCATH SYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events
biz.yahoo.com - January 26 at 5:52 PM

Social

Chart

Delcath Systems (DCTH) Chart for Saturday, July, 22, 2017

This page was last updated on 7/22/2017 by MarketBeat.com Staff